CD4 and neoplasm: Transgenic mice lacking LEC-specific MHC-II expression displayed attenuated heterotopic tumor growth, accompanied by elevated numbers of tumor-specific CD8+ and effector CD4+ T cells, as well as reduced numbers of T regulatory CD4+ cells in the TME (104).